Nu-Med Plus (NUMD) Cost of Revenue (2023 - 2024)
Nu-Med Plus recorded quarterly Cost of Revenue of $300.0 in Q1 2024, down 90.0% quarter-over-quarter from $3000.0 in Q4 2023.
Nu-Med Plus' Cost of Revenue history runs 2 years deep, the most recent figure standing at $300.0 for Q1 2024.
- In Q1 2024, Cost of Revenue changed N/A year-over-year to $300.0; the TTM figure through Dec 2024 stood at $300.0 (changed N/A YoY), while the FY2025 annual figure was $58.0, down 80.67% from the prior year.
- Cost of Revenue came in at $300.0 for Q1 2024 at Nu-Med Plus, down from $3000.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $3300.0 in Q3 2023 to a low of $300.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.26 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.51 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 441.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 481.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 891.20 Mn |
| 10 | Nu-Med Plus | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 300.00 |
| Mar 31, 2024 | 300.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,300.00 |
| Sep 30, 2023 | 3,300.00 |